Dora Kholodenko

1 ta ish

Athena Group (United States)

1. Reduction of β‐amyloid peptide₄₂ in the cerebrospinal fluid of patients with Alzheimer's disease

   Ruth Motter, Carmen Vigo‐Pelfrey, Dora Kholodenko +14

   Maqola19952 iqtibos

   ABIABI:AkademIndex/2026.other.775789